# EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

> **NCT03950076** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Population Health Research Institute** · enrollment: 948 (actual)

## Conditions studied

- Intracranial Hemorrhages
- Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban
- **OTHER:** Non-anticoagulant medical therapy

## Key facts

- **NCT ID:** NCT03950076
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-20
- **Primary completion:** 2026-05-13
- **Final completion:** 2026-05-13
- **Target enrollment:** 948 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950076, "EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03950076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*